This results in increased use of health care resources, including the need for hospitalization and the use of nonconventional medication [4]
Although the use of first-generation uncouplers (e.g., dinitrophenol, DNP) was limited by significant toxicity, subsequent experimental studies and early clinical observations have highlighted the potential benefits of controlled mitochondrial uncoupling in both metabolic diseases and cancer (Goedeke and Shulman, 2021
World J Diabetes 7:572598 Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M (2008) Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and independent pathways
These transient compositions or intermediate compositions arise when a process step is performed and they are expressly included as invention embodiments whenever AD and an alkaline excipient are contacted or are present together